European equities traded in the US as American depositary receipts were falling sharply late Monday morning, dropping 1.78% to 1,814.49 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by petroleum refiner Equinor (EQNR) and telecommunications company Nokia (NOK), which climbed 6.2% and 4.8% respectively. They were followed by biotech firm Evaxion (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which advanced 3.8% and 2.7% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which fell 4.1% and 4% respectively. They were followed by health care tech company Royal Philips (PHG) and lender Banco Santander (SAN), which were down 3.5% and 3.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX) and pharmaceutical company Silence Therapeutics (SLN), which rose 5.8% and 5.2% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and oil and gas company BP (BP), which were up 5% and 1.3% respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and communications company WPP (WPP), which dropped 8.8% and 6.2% respectively. They were followed by hospitality company InterContinental Hotels Group (IHG) and lender HSBC (HSBC), which lost 4.6% and 3.9% respectively.